Thomaidou Agathi, Deda Olga, Begou Olga, Lioupi Artemis, Kontou Angeliki, Gika Helen, Agakidou Eleni, Theodoridis Georgios, Sarafidis Kosmas
1st Department of Neonatology, School of Medicine, Aristotle University of Thessaloniki, Hippokrateion General Hospital, 54642 Thessaloniki, Greece.
Laboratory of Forensic Medicine and Toxicology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
J Clin Med. 2022 Sep 7;11(18):5270. doi: 10.3390/jcm11185270.
Late-onset sepsis (LOS) and necrotizing enterocolitis (NEC) are major causes of neonatal morbidity and mortality. In this prospective, case-control study, we evaluated the metabolic profile of neonates with LOS and NEC. Blood samples were collected from 15 septic neonates and 17 neonates with NEC at the clinical suspicion of the specific diseases. Sixteen gestational and postnatal age-matched neonates without sepsis/NEC served as controls. Serum metabolic profiles were assessed using liquid chromatography-quadrupole time-of-flight mass spectrometry. Metabolomic analysis revealed significant differences in the metabolic profile of neonates with LOS or NEC compared to controls. More specifically, a number of molecules possibly identified as phosphatidylcholines or lysophosphatidylcholines were found to be significantly reduced both in neonates with LOS and those with NEC compared to controls. Additionally, L-carnitine could efficiently discriminate NEC cases from controls. The results of the current study suggest that certain phospholipids and their derivatives could possibly be used as biomarkers for the early detection of LOS and NEC.
迟发性败血症(LOS)和坏死性小肠结肠炎(NEC)是新生儿发病和死亡的主要原因。在这项前瞻性病例对照研究中,我们评估了患有LOS和NEC的新生儿的代谢谱。在临床怀疑患有特定疾病时,从15名败血症新生儿和17名患有NEC的新生儿中采集血样。16名胎龄和出生后年龄匹配且无败血症/NEC的新生儿作为对照。使用液相色谱-四极杆飞行时间质谱法评估血清代谢谱。代谢组学分析显示,与对照组相比,患有LOS或NEC的新生儿的代谢谱存在显著差异。更具体地说,发现一些可能被鉴定为磷脂酰胆碱或溶血磷脂酰胆碱的分子在患有LOS的新生儿和患有NEC的新生儿中均比对照组显著减少。此外,左旋肉碱可以有效地区分NEC病例与对照组。本研究结果表明,某些磷脂及其衍生物可能用作早期检测LOS和NEC的生物标志物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2019-4-8
Int J Immunopathol Pharmacol. 2020
J Proteome Res. 2025-6-6
BMC Gastroenterol. 2024-10-26
Metabolites. 2023-12-24
Int J Mol Sci. 2021-10-28